This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa

This study has been completed.
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by:
CIPRA SA
ClinicalTrials.gov Identifier:
NCT00096681
First received: November 12, 2004
Last updated: February 17, 2011
Last verified: February 2011
History of Changes
Results First Received: January 14, 2011  
Study Type: Observational
Study Design: Observational Model: Ecologic or Community;   Time Perspective: Prospective
Conditions: HIV Infections
Tuberculosis

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Participants From the Community The number of participants from the community who attended the clinic for a once off study visit

Participant Flow:   Overall Study
    Participants From the Community
STARTED   762 
COMPLETED   762 
NOT COMPLETED   0 



  Baseline Characteristics
  Show Baseline Characteristics


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Number of Participants With Microbiologically Confirmed Pulmonary Tuberculosis   [ Time Frame: Pulmonary Tuberculosis diagnosed from sputum sample obtained at the study visit ]
  Show Outcome Measure 1

2.  Secondary:   Number of Participants With a Positive HIV Test   [ Time Frame: HIV status at the time of the study visit ]
  Show Outcome Measure 2


  Serious Adverse Events
  Show Serious Adverse Events


  Other Adverse Events
  Show Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Show More Information